financetom
Business
financetom
/
Business
/
Riskified Swings to Q3 Adjusted Profit, Revenue Climbs; 2024 Revenue Guidance Increased
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Riskified Swings to Q3 Adjusted Profit, Revenue Climbs; 2024 Revenue Guidance Increased
Nov 13, 2024 4:57 AM

07:31 AM EST, 11/13/2024 (MT Newswires) -- Riskified ( RSKD ) reported Q3 adjusted earnings Wednesday of $0.03 per diluted share, swinging from an adjusted loss of $0.02 a year earlier.

Analysts polled by Capital IQ expected earnings of $0.02.

Revenue for the quarter ended Sept. 30 was $78.8 million, up from $71.9 million a year earlier.

Analysts surveyed by Capital IQ expected $75.1 million.

For 2024, the e-commerce fraud consulting firm raised its revenue outlook to be between $322 million and $327 million from its prior outlook of $320 million to $325 million. Analysts surveyed by Capital IQ expect $321.7 million.

The company also authorized the repurchase of up to $75 million of the company's shares, adding to its existing $150 million authorization, of which about $140 million has already been utilized.

Shares of Riskified ( RSKD ) rose more than 16% in recent premarket activity.

Price: 4.98, Change: +0.69, Percent Change: +16.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life Sciences
Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life Sciences
Nov 4, 2025
NEW YORK and CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc ( RPRX ) today announced that it has acquired a royalty interest in Alnylam’s AMVUTTRA from funds managed by Blackstone Life Sciences (“Blackstone”) for $310 million. The royalty interest being sold stems from Blackstone’s 2020 financing collaboration with Alnylam, in which Blackstone invested to support AMVUTTRA’s...
Intuitive Machines to broaden space business with $800 million deal for Lanteris
Intuitive Machines to broaden space business with $800 million deal for Lanteris
Nov 4, 2025
(Reuters) -Lunar lander maker Intuitive Machines ( LUNR ) said on Tuesday it will buy Lanteris Space Systems, a spacecraft maker formerly known as Maxar Space Systems, from private equity firm Advent International in a deal worth $800 million. The move takes Intuitive Machines ( LUNR ) beyond its lunar niche as the company aims to become a full-service space...
EnPro Q3 results beat estimates on demand for precision cleaning solutions
EnPro Q3 results beat estimates on demand for precision cleaning solutions
Nov 4, 2025
Overview * EnPro ( NPO ) Q3 sales rise 9.9%, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong operational performance * Company announces strategic acquisitions to expand Sealing Technologies capabilities Outlook * EnPro ( NPO ) updates 2025 revenue growth guidance to 7%-8% * Company expects 2025 adjusted EBITDA of $275 mln to $280 mln *...
Pfizer raises 2025 profit forecast for second time in a row
Pfizer raises 2025 profit forecast for second time in a row
Nov 4, 2025
Nov 4 (Reuters) - Pfizer ( PFE ) lifted its full-year profit forecast for the second time in a row on Tuesday, buoyed by strong demand for its blockbuster heart treatment and blood thinner. The company said it expects adjusted earnings of $3.00 to $3.15 per share, up from its prior view of $2.90 to $3.10. (Reporting by Mrinalika Roy...
Copyright 2023-2026 - www.financetom.com All Rights Reserved